These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26418303)

  • 1. Pretransfusion Comparison of Dialyser-Based Hemoconcentrator With Cell Saver System for Perioperative Cell Salvage.
    Garg P; Malhotra A; Desai M; Sharma P; Bishnoi AK; Tripathi P; Rodricks D; Pandya H
    Innovations (Phila); 2015; 10(5):334-41. PubMed ID: 26418303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
    Niranjan G; Asimakopoulos G; Karagounis A; Cockerill G; Thompson M; Chandrasekaran V
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):271-7. PubMed ID: 16829083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell salvage during coronary artery bypass surgery and allogenic blood exposure.
    Al-Mandhari S; Maddali MM; Al-Bahrani MJ
    Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):913-6. PubMed ID: 26113735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of two methods for salvaging red blood cells: centrifugation techniques (cell-saver) versus filtration through a 100,000-dalton filter].
    Catalá Bauset JC; de Andrés Ibáñez J; Grau Real F; Bengtsson A; Bengtson JP
    Rev Esp Anestesiol Reanim; 1999 Oct; 46(8):338-43. PubMed ID: 10563139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pump blood processing, salvage and re-transfusion improves hemoglobin levels after coronary artery bypass grafting, but affects coagulative and fibrinolytic systems.
    Scrascia G; Rotunno C; Nanna D; Rociola R; Guida P; Rubino G; de Luca Tupputi Schinosa L; Paparella D
    Perfusion; 2012 Jul; 27(4):270-7. PubMed ID: 22440640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):852-60. PubMed ID: 24434302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a cell saver necessary in off-pump coronary artery bypass surgery?
    Tan NL; Corbineau H; Phu BD; Verhoye JP
    Asian Cardiovasc Thorac Ann; 2012 Oct; 20(5):539-43. PubMed ID: 23087296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial.
    Murphy GJ; Rogers CS; Lansdowne WB; Channon I; Alwair H; Cohen A; Caputo M; Angelini GD
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):20-8. PubMed ID: 15999036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intraoperative blood salvage during coronary artery bypass grafting.
    Lee J; Ikeda S; Johnston MF
    Minerva Cardioangiol; 1997 Sep; 45(9):395-400. PubMed ID: 9436350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cell saver in reducing homologous blood transfusions during OPCAB surgery: a prospective randomized trial.
    Goel P; Pannu H; Mohan D; Arora R
    Transfus Med; 2007 Aug; 17(4):285-9. PubMed ID: 17680954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autotransfusion after cardiac surgery. Hematological, biochemical and immunological properties of shed mediastinal blood].
    Salas Millán J; de Vega N; Carmona Aurioles J; Negri Arjona S; García-Vallejo J; Muñoz Gómez M
    Rev Esp Anestesiol Reanim; 2001 Mar; 48(3):122-30. PubMed ID: 11333796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of a simple cardiotomy suction system as a blood salvage procedure during off-pump coronary artery bypass surgery.
    Yasukawa T; Manabe S; Hiraoka D; Hirayama D; Kinoshita R; Komori M; Hosokawa M; Hirooka K
    J Artif Organs; 2019 Sep; 22(3):194-199. PubMed ID: 30968273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of haemostatic biomarkers during low-risk patients undergoing cardiopulmonary bypass using either conventional centrifugal cell salvage or the HemoSep device.
    Boyle G; Kuffel A; Parmar K; Gibson K; Smith M; Grehan A; Hunt BJ; Chambers DJ
    Perfusion; 2019 Jan; 34(1):76-83. PubMed ID: 30067140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell saver does not increase pro-inflammatory cytokine levels and expression of adhesive molecules in the salvaged blood of patients undergoing off-pump coronary artery bypass surgery.
    Lin TY; Chen Y; Chiu KM; Lu CW; Jean WH; Horng FM; Chu SH
    Acta Anaesthesiol Taiwan; 2005 Dec; 43(4):211-5. PubMed ID: 16450595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient blood management in elective total hip- and knee-replacement surgery (Part 1): a randomized controlled trial on erythropoietin and blood salvage as transfusion alternatives using a restrictive transfusion policy in erythropoietin-eligible patients.
    So-Osman C; Nelissen RG; Koopman-van Gemert AW; Kluyver E; Pöll RG; Onstenk R; Van Hilten JA; Jansen-Werkhoven TM; van den Hout WB; Brand R; Brand A
    Anesthesiology; 2014 Apr; 120(4):839-51. PubMed ID: 24424070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intraoperatively salvaged and washed blood on stimulated cytokine release in vitro.
    Schneider SO; Rensing H; Hartmann L; Grundmann U; Volk T; Biedler A
    Transfusion; 2014 Oct; 54(10 Pt 2):2782-90. PubMed ID: 25294235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of cell saver method in the surgical treatment of adolescent idiopathic scoliosis.
    Akgül T; Dikici F; Ekinci M; Buget M; Polat G; Sar C
    Acta Orthop Traumatol Turc; 2014; 48(3):303-6. PubMed ID: 24901921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the Cell Saver Autotransfusion Device be used routinely in all infrarenal abdominal aortic bypass operations?
    Kelley-Patteson C; Ammar AD; Kelley H
    J Vasc Surg; 1993 Aug; 18(2):261-5. PubMed ID: 8350435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of recovery of cardiopulmonary bypass residual blood: cell saver vs. hemoconcentrator.
    Johnson HD; Morgan MS; Utley JR; Leyand SA; Nguyen-Duy T; Crawley DM
    J Extra Corpor Technol; 1994 Dec; 26(4):194-9. PubMed ID: 10150684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood conservation for myocardial revascularization. Is it cost effective?
    Breyer RH; Engelman RM; Rousou JA; Lemeshow S
    J Thorac Cardiovasc Surg; 1987 Apr; 93(4):512-22. PubMed ID: 3104693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.